Cargando…
Current perspective of neuroprotection and glaucoma
Glaucoma is the second leading cause of blindness worldwide and is most notably characterized by progressive optic nerve atrophy and advancing loss of retinal ganglion cells (RGCs). The main concomitant factor is the elevated intraocular pressure (IOP). Existing treatments are focused generally on l...
Autores principales: | Tian, Kailin, Shibata-Germanos, Shannon, Pahlitzsch, Milena, Cordeiro, M Francesca |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4646599/ https://www.ncbi.nlm.nih.gov/pubmed/26635467 http://dx.doi.org/10.2147/OPTH.S80445 |
Ejemplares similares
-
Glaucoma: the retina and beyond
por: Davis, Benjamin Michael, et al.
Publicado: (2016) -
Topical Coenzyme Q10 demonstrates mitochondrial-mediated neuroprotection in a rodent model of ocular hypertension
por: Davis, Benjamin Michael, et al.
Publicado: (2017) -
New perspectives of immunomodulation and neuroprotection in glaucoma
por: Skopiński, Piotr, et al.
Publicado: (2021) -
Topical Curcumin Nanocarriers are Neuroprotective in Eye Disease
por: Davis, Benjamin M., et al.
Publicado: (2018) -
Neuroprotection in Glaucoma
por: Doozandeh, Azadeh, et al.
Publicado: (2016)